DKSC (Dakshidin) EPS (Diluted): $ (TTM As of Sep. 2023)


What is Dakshidin EPS (Diluted)?

Dakshidin DKSC +33.33% EPS (Diluted) is $ as of Sep. 2023.

Dakshidin's Earnings per Share (Diluted) for the three months ended in Sep. 2023 was $0.00.

Dakshidin's EPS (Basic) for the three months ended in Sep. 2023 was $0.00.

Dakshidin's EPS without NRI for the three months ended in Sep. 2023 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Dakshidin  (OTCPK:DKSC) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Dakshidin EPS (Diluted) Related Terms

Dakshidin EPS (Diluted) Historical Data

* Premium members only.

The historical data trend for Dakshidin's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dakshidin EPS (Diluted) Chart

Dakshidin Annual Data
Trend
EPS (Diluted)

Dakshidin Quarterly Data
Mar19 Mar20 Sep22 Sep23
EPS (Diluted) 0.00 0.00 0.00 0.00

DKSC vs ECEZ, AFBG, CESX: EPS (Diluted) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Dakshidin's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dakshidin PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dakshidin's PE Ratio distribution charts can be found below:

* The bar in red indicates where Dakshidin's PE Ratio falls into.


Dakshidin EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Dakshidin's Diluted EPS for the fiscal year that ended in . 20 is calculated as

Diluted EPS (A: . 20 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-)/0
=

Dakshidin's Diluted EPS for the quarter that ended in Sep. 2023 is calculated as

Diluted EPS (Q: Sep. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-0.002-0)/2578.760
=-0.00

Frequently Asked Questions Learn more about EPS (Diluted) →
What does a EPS (Diluted) of $ mean?
Dakshidin (DKSC) has a EPS (Diluted) of $ as of Sep. 2023. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Dakshidin and its competitors.
Is Dakshidin's EPS (Diluted) too high?
Dakshidin's current EPS (Diluted) is $.
How does Dakshidin's EPS (Diluted) compare to ECEZ and AFBG?
Dakshidin's EPS (Diluted) of $ can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Diluted) for a Drug Manufacturers company?
A good EPS (Diluted) depends on the Drug Manufacturers industry context. However, EPS (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Diluted) mean?
A high EPS (Diluted) can signal that a stock is expensive relative to its fundamentals. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Dakshidin and its competitors. Dakshidin's current EPS (Diluted) is $. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dakshidin stock overvalued right now?
Dakshidin (DKSC) has a current EPS (Diluted) of $. The current EPS (Diluted) is $. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Diluted) calculated?
EPS (Diluted) is calculated from a company's financial statements. For Dakshidin (DKSC), the current EPS (Diluted) is $ as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Dakshidin Business Description

Address 508 Locust Street, Lockport, NY, USA, 14094
Dakshidin Corp is a Cannabis-based medical product company. The company operates through its online e-commerce store laughingfrogs.com. The company is composed of four synergistic entities: Laughing Frogs, an online sales portal for the company's CBD products; Laughing Frogs Nutraceutical the online sales portal for all non-CBD hemp oil products and its proprietary nutraceutical products, company's new PPE division and Runnymede Farms, a company that is focused on the cultivation of specifically grown Hemp plants. through its growing operations and Joint Ventures with established growers.